Expertise in
26
conditions

Dr. Phioanh L. Nghiemphu

Neurology
Office
300 Medical Plz, 
Los Angeles, CA 
Clinical Trials:Currently Recruiting for 1 Trial
Offers Telehealth
Expertise in
26
conditions
Office
300 Medical Plz, 
Los Angeles, CA 

Overview

Phioanh Nghiemphu is a Neurologist practicing medicine in Los Angeles, California.

Dr. Nghiemphu is highly rated in 26 conditions, according to our data. Her clinical expertise encompasses Glioma, Glioblastoma, Astrocytoma, and Brain Tumor.

She is actively involved in clinical research, co-authoring 136 peer reviewed articles and participating in 5 clinical trials.

Specialties

Neurology

Licenses

Psychiatry & Neurology in CA

Hospital Affiliations

Ronald Reagan UCLA Medical Center
Santa Monica - UCLA Med Ctr & Orthopaedic Hospital

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
LA Care
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 8 Less Insurance Carriers -

Locations

Office
300 Medical Plz, Los Angeles, CA 90095

Additional Areas of Focus

Dr. Nghiemphu has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Neurofibromatosis Type 1 (NF1)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

GBM AGILE: Global Adaptive Trial Master Protocol: An International, Seamless Phase II/III Response Adaptive Randomization Platform Trial Designed To Evaluate Multiple Regimens In Newly Diagnosed and Recurrent GBM
GBM AGILE: Global Adaptive Trial Master Protocol: An International, Seamless Phase II/III Response Adaptive Randomization Platform Trial Designed To Evaluate Multiple Regimens In Newly Diagnosed and Recurrent GBM
Enrollment Status: Recruiting
Publish Date: July 30, 2026
Intervention Type: Drug, Radiation, Biological
Study Drugs: Temozolomide, Lomustine, Regorafenib, Paxalisib, VAL-083
Study Phase: Phase 2/Phase 3
A Phase 2b Trial of the MEK 1/2 Inhibitor (MEKi) PD-0325901 in Adult and Pediatric Patients With Neurofibromatosis Type 1 (NF1)-Associated Inoperable Plexiform Neurofibromas (PNs) That Are Causing Significant Morbidity
A Phase 2b Trial of the MEK 1/2 Inhibitor (MEKi) PD-0325901 in Adult and Pediatric Patients With Neurofibromatosis Type 1 (NF1)-Associated Inoperable Plexiform Neurofibromas (PNs) That Are Causing Significant Morbidity
Enrollment Status: Active_not_recruiting
Publish Date: July 10, 2026
Intervention Type: Drug
Study Drug: Mirdametinib
Study Phase: Phase 2
Pilot Study of MLN0128 (TAK-228) in Preoperative Recurrent Glioblastoma (GBM) Patients
Pilot Study of MLN0128 (TAK-228) in Preoperative Recurrent Glioblastoma (GBM) Patients
Enrollment Status: Terminated
Publish Date: April 04, 2024
Intervention Type: Other, Drug, Procedure
Study Drug: Sapanisertib
Study Phase: Phase 1
A Single Arm, Monocenter Phase II Trial of RAD001 as Monotherapy in the Treatment of Neurofibromatosis Type 2 - Related Vestibular Schwannoma
A Single Arm, Monocenter Phase II Trial of RAD001 as Monotherapy in the Treatment of Neurofibromatosis Type 2 - Related Vestibular Schwannoma
Enrollment Status: Terminated
Publish Date: February 13, 2024
Intervention Type: Drug
Study Drug: Everolimus
Study Phase: Phase 2
Phase 1b Study of ONC201 and Radiotherapy in Preoperative Recurrent Glioblastoma (GBM) Patients
Phase 1b Study of ONC201 and Radiotherapy in Preoperative Recurrent Glioblastoma (GBM) Patients
Enrollment Status: Withdrawn
Publish Date: May 12, 2021
Intervention Type: Procedure, Drug, Radiation
Study Phase: Phase 1
View 4 Less Clinical Trials

136 Total Publications

Clinical and radiographic prognostic factors in recurrent contrast-enhancing IDH-mutant gliomas treated with bevacizumab.
Clinical and radiographic prognostic factors in recurrent contrast-enhancing IDH-mutant gliomas treated with bevacizumab.
Journal: Neuro-oncology advances
Published: December 29, 2025
Similar Doctors
Expertise in
21
conditions
Expertise in
21
conditions
Referral may be required

UCLA Health Westwood Neurology

300 UCLA Medical Plz Ste B200, 
Los Angeles, CA 
 (0.1 miles away)
310-794-1195
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Timothy Cloughesy is a Neurologist practicing medicine in Los Angeles, California. Dr. Cloughesy is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Glioblastoma, Astrocytoma, Glioma, and Brain Tumor.

Expertise in
53
conditions
Expertise in
53
conditions
Referral may be required

Office

300 Medical Plz, 
Los Angeles, CA 
 (0.1 miles away)
310-794-1195
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Susan Perlman is a Neurologist practicing medicine in Los Angeles, California. Dr. Perlman is highly rated in 53 conditions, according to our data. Her clinical expertise encompasses Spinocerebellar Ataxia, Friedreich Ataxia, Drug Induced Dyskinesia, and Olivopontocerebellar Atrophy.

Expertise in
47
conditions
Expertise in
47
conditions
Referral may be required

UCLA Health Westwood Neurology

300 UCLA Medical Plz Ste B200, 
Los Angeles, CA 
 (0.1 miles away)
310-794-1195
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Perry Shieh is a Neurologist practicing medicine in Los Angeles, California. Dr. Shieh is highly rated in 47 conditions, according to our data. His clinical expertise encompasses Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, Spinal Muscular Atrophy (SMA), and Tubular Aggregate Myopathy.

Frequently Asked Questions about Dr. Phioanh L. Nghiemphu

How do I make an appointment with Dr. Phioanh L. Nghiemphu?

You can book an appointment with Dr. Phioanh L. Nghiemphu by calling their office at 310-794-1195. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Phioanh L. Nghiemphu a top-rated expert for Glioma?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Phioanh L. Nghiemphu is classified as an Elite expert for Glioma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Phioanh L. Nghiemphu specialize in?

While Dr. Phioanh L. Nghiemphu is a Neurology, they have specific expertise in Glioma, Glioblastoma, and Astrocytoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Neurology.

Does Dr. Phioanh L. Nghiemphu participate in research or clinical trials?

Yes. Dr. Phioanh L. Nghiemphu has published 136 articles and abstracts on conditions like Glioma. You can view a list of Dr. Phioanh L. Nghiemphu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Phioanh L. Nghiemphu accept my insurance?

Dr. Phioanh L. Nghiemphu accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 310-794-1195 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Nghiemphu's expertise for a condition
ConditionClose
View All 8 Elite Conditions
View All 16 Distinguished Conditions
View All 19 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile